openPR Logo
Press release

Brain Ischemia Pipeline Therapeutics Market Review H1 2017

08-23-2017 01:46 PM CET | Health & Medicine

Press release from: ReportsnReports

Brain Ischemia Pipeline Therapeutics Market Review H1 2017

Brain Ischemia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Brain Ischemia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 10 and 1 respectively. Brain ischemia is a stroke is when the blood supply to any part of the brain is interrupted, resulting in tissue death and loss of brain function. Treatment includes analgesics to control severe headache, anti-hypertensive medication to control high blood pressure and anti-platelet agents.

Inquire for Complete Brain Ischemia - Pipeline Review, H1 2017 Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1010748 .

This report reviews key companies involved in Brain Ischemia (Central Nervous System) therapeutics and enlists all their major and minor projects.
Companies Discussed - CohBar Inc, Lixte Biotechnology Holdings Inc, NeuroNascent Inc, NeurOp Inc, NoNO Inc, Prolong Pharmaceuticals LLC, Spectrum Pharmaceuticals Inc, Vect-Horus SAS.

Brain Ischemia pipeline guide features descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
Brain Ischemia Drug Profiles Discussed - 2-CCPA, AB-002, ADA-409, CIDEM-161, CIGB-845, Humanin, LAU-0901, LB-100, NP-10679, phycocyanobilin, Recombinant Protein to Activate GDNF for Brain Ischemia, Sanguinate, Small Molecules for Brain Ischemia, Small Molecules to Antagonize Gpr17 for Brain Ischemia, Small Molecules to Antagonize TRPM7 for Oncology, Ophthalmology, Cardiovascular and Central nervous System Disorders, SPI-1620, Stem Cell Therapy for Ischemia, Synthetic Peptide for Central Nervous System Disorders, VHN-439

To Get Discount on This Report Visit: http://www.reportsnreports.com/contacts/discount.aspx?name=1010748 (This report is available at up to 25% Discount till June 02nd 2017).

Brain Ischemia pipeline report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Table of Contents:

1. Global Markets Report Coverage
2. Brain Ischemia - Overview
3. Brain Ischemia - Therapeutics Development
4. Brain Ischemia Pipeline Overview
5. Brain Ischemia Pipeline by Companies
6. Brain Ischemia Pipeline by Universities/Institutes
7. Brain Ischemia Products under Development by Companies
8. Brain Ischemia Products under Development by Universities/Institutes
9. Brain Ischemia - Therapeutics Assessment
10. Assessment by Target
11. Assessment by Mechanism of Action
12. Assessment by Route of Administration
13. Assessment by Molecule Type
14. Brain Ischemia - Companies Involved in Therapeutics Development

Direct Purchase This Report at http://www.reportsnreports.com/purchase.aspx?name=1010748 .

Reportnreports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 500,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
India.
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Brain Ischemia Pipeline Therapeutics Market Review H1 2017 here

News-ID: 552086 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Brain

Retro X Focus Nootropic Brain Booster - SUPERCHARGED BRAIN PERFORMANCE!
Retro X Focus Nootropic Brain Booster is a state-of-the-art nootropic that employs vitamins, vital nutrients, plus amino acids to assist you to think quicker, cleverer, smarten your memory, and improve attention and leave you feeling invigorated. The water-soluble extracts, which are useful in product additives, function to rejuvenate studying approaches and thinking. Official Online Store - https://www.allnutritionhub.com/get-retro-x-focus-nootropic How does the Retro X Focus Function? It is common knowledge that we must work out
Cogni Brain 360 - Does It Really Work For Brain Health!
Cogni Brain 360 Some signs of cerebrum depression include mental and emotional upheavals and feelings that are not predictable. Many of these symptoms occur when your brain isn't in a stable state or not receiving the necessary supplements. Official Website: CLICK HERE=> https://dmocoz.com/order-cognibrain360 Cogni Brain 360 - What is it? Cogni Brain 360This causes mental decrease in a normal setting and accelerates psychological rot. It can also cause severe and long-lasting mental damage
Brain Cancer Diagnostics Market: Increase in Prevalence of Brain Cancer Worldwid …
The scope of the brain cancer diagnostics market includes diagnostic type, cancer type, end user, and region. The brain cancer diagnostics market is analyzed based on regions such as North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the brain cancer diagnostics market, emphasizing various parameters such as market trends, technological advancements, market dynamics, and competitive
Geehii Brain Pills Review-Does Geehii Brain Work-Complete Info
Your thoughts is what makes you who you're. It consists of your recollections, personality, and selection-making strategies. We need to inform you about a supplement known as Geehii Brain Pills. This is a method that aid mind fitness and help you reap your complete capacity. After all, you consume proper and workout to maintain your body wholesome, why wouldn’t you do something to make certain you mind remains as wholesome
Wireless Brain Sensors Market 2017- EMOTIV, Advanced Brain Monitoring, Muse, Neu …
Apex Market Reports, recently published a detailed market research study focused on the "Wireless Brain Sensors Market" across the global, regional and country level. The report provides 360° analysis of "Wireless Brain Sensors Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Wireless Brain Sensors industry, and estimates the future trend of
4th International conference on Brain Disorders and Brain Injury
Dear Members, I hope you are doing well This is Karlin Zoe; we would like to invite at our upcoming 4th International Conference on Brain Disorder and Brain Injury on August 14-16, 2017 at Toronto, Canada Participate at this conference and earn up to 20 AMA PRA Category 1 Credits TM Mark your calendar as busy on August 14-16, 2017; they are the official dates for the Brain Injury 2017. Participation benefits: Claim CME